Diacylglycerol kinase kappa is a target of the Prader–Willi syndrome gene SNORD116
Life Science Alliance · 2027-01 · 10 (1) · e202603723
DOI: 10.26508/lsa.202603723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, online erschienen am 04.11.2026. Verfasst von Yiying Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Division of Molecular Genetics, Columbia University Irving Medical Center, New York, NY, USA yz84@cumc.columbia.edu. Hauptthemen laut MEDLINE: Prader-Willi Syndrome, RNA, Small Nucleolar, Diacylglycerol Kinase. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Foundation for Prader–Willi Research, Levo Therapeutics, Inc..
Abstract (Originalsprache)
SNORD116 is a small nucleolar RNA deficient in Prader–Willi syndrome individuals. The mechanisms by which SNORD116 conveys its effects are unknown. Here, transcriptomic analysis showed that diacylglycerol kinase kappa ( Dgkk ) expression was elevated in the hypothalamus of Snord116 -deficient mice. In silico analyses predicted a strong RNA:RNA interaction between Snord116 and Dgkk mRNA that is fully conserved in mouse and human. In vitro experiments in human cellular models demonstrated that SNORD116 mediates 2′-O-methylation of DGKK mRNA and regulates DGKK mRNA and protein expression. In Snord116 -deficient mouse neurons, increased Dgkk expression was associated with attenuated diacylglycerol-mediated activation of ERK and PKC, critical elements in neuronal signaling cascades. In mice, brain Dgkk expression peaks during late embryonic and early postnatal periods, coinciding with peak rates of neurogenesis; its expression in adults is restricted mainly to brain regions implicated in Prader–Willi syndrome pathophysiology, including the arcuate nucleus of the hypothalamus. Fasting acutely decreased hypothalamic Dgkk expression in wild-type mice. Increased Dgkk expression in Snord116 -deficient mice could reflect derangements in this pathway that affects both brain development and cell-specific functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Division of Molecular Genetics, Columbia University Irving Medical Center, New York, NY, USA yz84@cumc.columbia.edu.
- Department of Pediatrics, Division of Molecular Genetics, Columbia University Irving Medical Center, New York, NY, USA.
- Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
- Foundation for Prader-Willi Research, Covina, CA, USA.
- Department of Pediatrics, Division of Genetics and Genomics, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
- Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA.
ORCID-Profile: Yiying Zhang, Gabriel F Batzli, Charles A LeDuc, George Stratigopoulos, Daniel G Carolan, Claudia A Doege, Rudolph L Leibel
Förderung
- NIDDK NIH HHS
- Foundation for Prader–Willi Research
- Levo Therapeutics, Inc.
- Russell Berrie Foundation
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Zhang, Y., Guo, K., Batzli, G. F., Zhao, H., Burnett, L. C., LeDuc, C. A., Stratigopoulos, G., Carolan, D. G., Doege, C. A., Shen, Y., & Leibel, R. L. (2027). Diacylglycerol kinase kappa is a target of the Prader–Willi syndrome gene SNORD116. Life Science Alliance, 10(1), e202603723. https://doi.org/10.26508/lsa.202603723
Vancouver
Zhang Y, Guo K, Batzli GF, Zhao H, Burnett LC, LeDuc CA, et al. Diacylglycerol kinase kappa is a target of the Prader–Willi syndrome gene SNORD116. Life Science Alliance. 2027;10(1):e202603723. doi:10.26508/lsa.202603723
BibTeX
@article{Zhang2027,
author = {Zhang, Yiying and Guo, Kaiying and Batzli, Gabriel F and Zhao, Haoquan and Burnett, Lisa C and LeDuc, Charles A and Stratigopoulos, George and Carolan, Daniel G and Doege, Claudia A and Shen, Yufeng and Leibel, Rudolph L},
title = {Diacylglycerol kinase kappa is a target of the Prader–Willi syndrome gene SNORD116},
journal = {Life Science Alliance},
year = {2027},
volume = {10},
number = {1},
pages = {e202603723},
doi = {10.26508/lsa.202603723}
}
EUVIMED